TREA

79324525 - ELATIVE

Follow

Information

  • Trademark
  • 79324525
  • Serial Number
    79324525
  • Registration Number
    6854744
  • Filing Date
    June 25, 2021
    3 years ago
  • Registration Date
    September 27, 2022
    2 years ago
  • Transaction Date
    January 25, 2023
    2 years ago
  • Status Date
    September 27, 2022
    2 years ago
  • Published for Opposition Date
    July 12, 2022
    2 years ago
  • Location Date
    September 27, 2022
    2 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    GILLES, DEBORAH LYNN M
  • Attorney Docket Number
    N&P-51822
    Attorney Name
    Ronald M. Kachmarik
    Law Office Assigned Location Code
    M10
  • Owners
Information
Mark Drawing Code
3000
Mark Identification
ELATIVE
Case File Statements
  • DM0000: The mark consists of the stylized word "ELATIVE" with the letters "ELATI" and the last letter "E" in blue and the letter "V" in orange.
  • GS0051: Pharmaceutical preparations for the prevention and treatment of liver diseases, cholesterol diseases, metabolic diseases, gastroenterological diseases, inflammatory diseases, auto-immune diseases and cancer diseases; chemical preparations for medical or pharmaceutical use, namely for the prevention and treatment of liver diseases, cholesterol diseases, metabolic diseases , gastroenterological diseases, inflammatory diseases, auto-immune diseases and cancer diseases; organic biological preparations for medical or pharmaceutical use, namely for the prevention and treatment of liver diseases, cholesterol diseases, metabolic diseases , gastroenterological diseases, inflammatory diseases, auto-immune diseases and cancer diseases; diagnostic preparations for medical use; diagnostic reagents for medical use
  • CC0000: The color(s) blue and orange is/are claimed as a feature of the mark.
  • GS0421: Scientific research for medical purposes; pharmaceutical research and development services; conducting clinical trials for others for pharmaceutical products, in particular conducting clinical trials for others for determining the efficacy and safety of elafibranor; conducting clinical trials for others to determine the efficacy and safety of pharmaceutical products in the treatment of primary biliary cholangitis (PBC); conducting scientific studies and analyses in the field of pharmaceuticals and medicines; scientific research and development, namely providing information, results and data relating to scientific or medical research and development of pharmaceutical products, especially from an online searchable database; medical and scientific research, namely conducting clinical trials for others; pharmaceutical and biological development and research services for third parties; clinical research for others in the field of pharmaceuticals and medicines; evaluation of the efficacy of pharmaceutical products
Case File Event Statements
  • 1/25/2023 - 2 years ago
    26 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 1/25/2023 - 2 years ago
    25 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 12/27/2022 - 2 years ago
    24 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 9/27/2022 - 2 years ago
    23 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 9/27/2022 - 2 years ago
    22 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 7/19/2022 - 2 years ago
    21 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 7/12/2022 - 2 years ago
    20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/12/2022 - 2 years ago
    19 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/29/2022 - 2 years ago
    18 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 6/29/2022 - 2 years ago
    17 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 6/22/2022 - 2 years ago
    16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/9/2022 - 2 years ago
    15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/8/2022 - 2 years ago
    14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/7/2022 - 2 years ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/7/2022 - 2 years ago
    12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 5/25/2022 - 2 years ago
    11 - REFUSAL PROCESSED BY IB Type: RFNT
  • 5/8/2022 - 2 years ago
    10 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 5/4/2022 - 2 years ago
    9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 5/4/2022 - 2 years ago
    8 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 3/25/2022 - 3 years ago
    7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 3/24/2022 - 3 years ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/17/2022 - 3 years ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/12/2021 - 3 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 11/8/2021 - 3 years ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/5/2021 - 3 years ago
    2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI
  • 10/28/2021 - 3 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR